Research internship report at Bluepharma Indústria Farmacêutica, S.A.
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Tipo de documento: | Dissertação |
Idioma: | eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | http://hdl.handle.net/10773/32117 |
Resumo: | This report intends to describe the work developed during the internship at Bluepharma Indústria Farmacêutica, S.A., in Research and Innovation sector. The first aim of this internship was to complete a review about long-acting injectables (LAI) and their characterization, as well as in vitro release. Thus, an overview of LAIs, their characterization methods, including in vitro release methods, possible membranes or barriers, and biorelevant characteristics is presented. The second aim was to support the development of the most appropriate methodology for assessing the release profile of LAI technology with an extended release of at least 96 hours develop internally. So, a description of developed activities is stated, presenting the rationale behind the choice of the method, the analytical development of the HPLC-PDA method to quantification of the drug substance (DS) and its pre-validation according to the authorities guidelines. Although the analytical method is already studied, the formulation development was not completed until the end of the internship, whereby the analytical method as well as the chosen method (including apparatus, barrier, ect.) to assess the in vitro release could need optimization with the final drug product. |
id |
RCAP_06f5b520d5a53b714ee98de0d7038e0e |
---|---|
oai_identifier_str |
oai:ria.ua.pt:10773/32117 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Research internship report at Bluepharma Indústria Farmacêutica, S.A.BiorelevanceLong-Acting Injectables (LAI)Extended-releaseCharacterization techniquesIn vitro releaseThis report intends to describe the work developed during the internship at Bluepharma Indústria Farmacêutica, S.A., in Research and Innovation sector. The first aim of this internship was to complete a review about long-acting injectables (LAI) and their characterization, as well as in vitro release. Thus, an overview of LAIs, their characterization methods, including in vitro release methods, possible membranes or barriers, and biorelevant characteristics is presented. The second aim was to support the development of the most appropriate methodology for assessing the release profile of LAI technology with an extended release of at least 96 hours develop internally. So, a description of developed activities is stated, presenting the rationale behind the choice of the method, the analytical development of the HPLC-PDA method to quantification of the drug substance (DS) and its pre-validation according to the authorities guidelines. Although the analytical method is already studied, the formulation development was not completed until the end of the internship, whereby the analytical method as well as the chosen method (including apparatus, barrier, ect.) to assess the in vitro release could need optimization with the final drug product.Este relatório pretende descrever o trabalho desenvolvido durante o estágio na Bluepharma Indústria Farmacêutica, S.A., no setor de Investigação e Inovação. O primeiro objetivo deste estágio consistia em realizar uma revisão da literatura sobre os injetáveis de ação prolongada (LAI) e a sua caracterização, incluindo testes de liberação in vitro. Assim, é apresentada uma visão geral sobre os LAI, os seus métodos de caracterização, incluindo métodos de libertação in vitro, possíveis membranas ou barreiras usadas e características biorelevantes aplicáveis ao estudo. O segundo objetivo envolvia o apoio ao desenvolvimento de uma metodologia adequada para avaliar o perfil de libertação de uma tecnologia LAI com libertação prolongada de pelo menos 96 horas desenvolvida internamente. Assim, na segunda parte do relatório é apresentada uma descrição das atividades desenvolvidas, expondo o racional para a escolha do método, o desenvolvimento analítico do método HPLC-PDA para quantificação do princípio ativo (DS) e sua pré-validação de acordo com as diretrizes das autoridades. Embora o método analítico já tenha sido estudado, o desenvolvimento da formulação não tinha sido concluído até o término do estágio, pelo que o método analítico, bem como o método escolhido para determinação do perfil de libertação in vitro (incluindo apparatus, barreira, etc.) podem necessitar de otimização com o produto final.2021-09-15T08:42:54Z2021-07-29T00:00:00Z2021-07-29info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://hdl.handle.net/10773/32117engFernandes, Mariana Amaralinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-02-22T12:02:10Zoai:ria.ua.pt:10773/32117Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:03:57.742998Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Research internship report at Bluepharma Indústria Farmacêutica, S.A. |
title |
Research internship report at Bluepharma Indústria Farmacêutica, S.A. |
spellingShingle |
Research internship report at Bluepharma Indústria Farmacêutica, S.A. Fernandes, Mariana Amaral Biorelevance Long-Acting Injectables (LAI) Extended-release Characterization techniques In vitro release |
title_short |
Research internship report at Bluepharma Indústria Farmacêutica, S.A. |
title_full |
Research internship report at Bluepharma Indústria Farmacêutica, S.A. |
title_fullStr |
Research internship report at Bluepharma Indústria Farmacêutica, S.A. |
title_full_unstemmed |
Research internship report at Bluepharma Indústria Farmacêutica, S.A. |
title_sort |
Research internship report at Bluepharma Indústria Farmacêutica, S.A. |
author |
Fernandes, Mariana Amaral |
author_facet |
Fernandes, Mariana Amaral |
author_role |
author |
dc.contributor.author.fl_str_mv |
Fernandes, Mariana Amaral |
dc.subject.por.fl_str_mv |
Biorelevance Long-Acting Injectables (LAI) Extended-release Characterization techniques In vitro release |
topic |
Biorelevance Long-Acting Injectables (LAI) Extended-release Characterization techniques In vitro release |
description |
This report intends to describe the work developed during the internship at Bluepharma Indústria Farmacêutica, S.A., in Research and Innovation sector. The first aim of this internship was to complete a review about long-acting injectables (LAI) and their characterization, as well as in vitro release. Thus, an overview of LAIs, their characterization methods, including in vitro release methods, possible membranes or barriers, and biorelevant characteristics is presented. The second aim was to support the development of the most appropriate methodology for assessing the release profile of LAI technology with an extended release of at least 96 hours develop internally. So, a description of developed activities is stated, presenting the rationale behind the choice of the method, the analytical development of the HPLC-PDA method to quantification of the drug substance (DS) and its pre-validation according to the authorities guidelines. Although the analytical method is already studied, the formulation development was not completed until the end of the internship, whereby the analytical method as well as the chosen method (including apparatus, barrier, ect.) to assess the in vitro release could need optimization with the final drug product. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-09-15T08:42:54Z 2021-07-29T00:00:00Z 2021-07-29 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/masterThesis |
format |
masterThesis |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10773/32117 |
url |
http://hdl.handle.net/10773/32117 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.source.none.fl_str_mv |
reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799137694944591872 |